Table 2 Median survival time from Kaplan–Meier curves
From: Correlation between overall survival and quality of life in colon cancer patients with chemotherapy
MST (months) | SD (months) | P-value | |
|---|---|---|---|
variable | |||
 timing diagnosed as inoperable | <0.01* | ||
  ICF | 21.3 | 1.8 | |
  ICR | 36.3 | 9.4 | |
 sex | <0.05* | ||
  female | 18.7 | 1.6 | |
  male | 23.1 | 2.6 | |
 age (years) | 0.691 | ||
  ≦70 | 21.3 | 2.8 | |
  >70 | 22.5 | 4.6 | |
 ECOG PS | 0.066 | ||
  0 | 29.9 | 4.9 | |
  1 | 18.7 | 3.3 | |
  2 | 20.8 | 12.1 | |
 primary site | 0.676 | ||
  right-sided | 28.8 | 12.3 | |
  left-sided | 21.3 | 1.9 | |
 histology | 0.651 | ||
  well differentiated | 23.1 | 6.4 | |
  moderately differentiated | 22.1 | 2.3 | |
  poorly or undifferentiated | 18.5 | 1.0 | |
 RAS | <0.05* | ||
  wild | 25.9 | 6.0 | |
  mutant | 18.9 | 1.9 | |
metastasis | |||
 liver | 0.153 | ||
  (-) | 21.2 | 7.5 | |
  (+) | 22.1 | 2.4 | |
 lung | 0.592 | ||
  (-) | 22.8 | 2.8 | |
  (+) | 16.2 | 2.5 | |
 peritoneum | 0.383 | ||
  (-) | 22.1 | 1.9 | |
  (+) | 18.6 | 4.5 | |
 locally advanced tumour | 0.415 | ||
  (-) | 22.5 | 2.0 | |
  (+) | 18.5 | 6.6 | |